122 related articles for article (PubMed ID: 22306944)
1. Serum IGF-1 linking visceral obesity with esophageal adenocarcinoma: unconvincing evidence.
McColl KE
Am J Gastroenterol; 2012 Feb; 107(2):205-6. PubMed ID: 22306944
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity.
Doyle SL; Donohoe CL; Finn SP; Howard JM; Lithander FE; Reynolds JV; Pidgeon GP; Lysaght J
Am J Gastroenterol; 2012 Feb; 107(2):196-204. PubMed ID: 22146489
[TBL] [Abstract][Full Text] [Related]
3. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma.
Donohoe CL; Doyle SL; McGarrigle S; Cathcart MC; Daly E; O'Grady A; Lysaght J; Pidgeon GP; Reynolds JV
Br J Surg; 2012 Mar; 99(3):387-96. PubMed ID: 22241325
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
Siahpush SH; Vaughan TL; Lampe JN; Freeman R; Lewis S; Odze RD; Blount PL; Ayub K; Rabinovitch PS; Reid BJ; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2387-95. PubMed ID: 18006928
[TBL] [Abstract][Full Text] [Related]
6. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.
MacDonald K; Porter GA; Guernsey DL; Zhao R; Casson AG
Cancer Epidemiol; 2009 Jul; 33(1):37-40. PubMed ID: 19679045
[TBL] [Abstract][Full Text] [Related]
7. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.
Adachi Y; Ohashi H; Imsumran A; Yamamoto H; Matsunaga Y; Taniguchi H; Nosho K; Suzuki H; Sasaki Y; Arimura Y; Carbone DP; Imai K; Shinomura Y
Tumour Biol; 2014 Feb; 35(2):973-85. PubMed ID: 24026884
[TBL] [Abstract][Full Text] [Related]
8. Absence or low IGF-1R-expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection.
De Bruijn K; Biermann K; Shapiro J; Dogan F; Spaander M; Janssen J; Wijnhoven B; Borsboom G; Hofland L; van Eijck C
J Surg Oncol; 2015 Jun; 111(8):1047-53. PubMed ID: 26082409
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma.
Zhao R; Macdonald K; Casson AG
Mol Carcinog; 2009 Nov; 48(11):982-8. PubMed ID: 19582762
[TBL] [Abstract][Full Text] [Related]
10. Insulin/IGF-1 Signaling Is Downregulated in Barrett's Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial.
Arcidiacono D; Zaramella A; Fabris F; Sánchez-Rodríguez R; Nucci D; Fassan M; Nardi M; Benna C; Cristofori C; Morbin T; Pucciarelli S; Fantin A; Realdon S
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684639
[TBL] [Abstract][Full Text] [Related]
11. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro].
Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma.
Choy B; Bandla S; Xia Y; Tan D; Pennathur A; Luketich JD; Godfrey TE; Peters JH; Sun J; Zhou Z
BMC Gastroenterol; 2012 Oct; 12():146. PubMed ID: 23078618
[TBL] [Abstract][Full Text] [Related]
13. Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions.
Iihara K; Shiozaki H; Oku K; Tahara H; Doki Y; Oka H; Kadowaki T; Iwazawa T; Inoue M; Mori T
Int J Cancer; 1993 Sep; 55(3):364-70. PubMed ID: 8375919
[TBL] [Abstract][Full Text] [Related]
14. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
15. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
16. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.
Takaoka M; Kim SH; Okawa T; Michaylira CZ; Stairs DB; Johnstone CN; Andl CD; Rhoades B; Lee JJ; Klein-Szanto AJ; El-Deiry WS; Nakagawa H
Cancer Biol Ther; 2007 Apr; 6(4):534-40. PubMed ID: 17457048
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.
Figueroa JD; Terry MB; Gammon MD; Vaughan TL; Risch HA; Zhang FF; Kleiner DE; Bennett WP; Howe CL; Dubrow R; Mayne ST; Fraumeni JF; Chow WH
Cancer Causes Control; 2009 Apr; 20(3):361-8. PubMed ID: 18989634
[TBL] [Abstract][Full Text] [Related]
18. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.
Corley DA; Kubo A; Zhao W
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):352-8. PubMed ID: 18268119
[TBL] [Abstract][Full Text] [Related]
19. Leptin and adiponectin receptor expression in oesophageal cancer.
Howard JM; Cathcart MC; Healy L; Beddy P; Muldoon C; Pidgeon GP; Reynolds JV
Br J Surg; 2014 May; 101(6):643-52. PubMed ID: 24664553
[TBL] [Abstract][Full Text] [Related]
20. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.
Kashyap MK
Tumour Biol; 2015 Nov; 36(11):8247-57. PubMed ID: 26369544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
